You are here: Industry Insights > drug

News List

Cidara and Mundipharma sign rezafungin drug development deal pharmaceutical-technology
September 05, 2019
US-based biotech Cidara Therapeutics has partnered with UK-based Mundipharma in a deal valued at more than $568m to develop and commercialise its anti-fungal drug rezafungin.
Experimental validation confirms the ability of artificial intelligence to accelerate drug discovery worldpharmanews
September 05, 2019
Insilico Medicine, a global leader in artificial intelligence for drug discovery, announced the publication of a paper titled, "Deep learning enables rapid identification of potent DDR1 kinase inhibitors," in Nature Biotechnology.
Brain disease drug delivery platform developed by researchers europeanpharmaceuticalreview
September 05, 2019
So-called ‘nanodiamonds’ could serve as a platform for diagnostic and therapeutic approaches for neurodegenerative diseases.
Experimental Drug Works Quickly on Major Depression drugs
September 05, 2019
Antidepressants typically take four to eight weeks to ease the debilitating symptoms of depression, but an early clinical trial found a new type of drug brought relief in just two weeks.
Four Pitfalls to Avoid When Packaging Injectable Drug Products contractpharma
September 05, 2019
When bringing a new injectable drug product to market, the packaging is quite important, especially considering the potential problems that can result with stability ...
Insilico Medicine develops new AI drug discovery system pharmaceutical-technology
September 04, 2019
Insilico Medicine has developed an artificial intelligence (AI)-powered system to facilitate the creation of therapeutic molecules.
China’s drug bulk-buy programme has been expanded europeanpharmaceuticalreview
September 04, 2019
China has expanded a pilot drug bulk-buying programme to almost the entire country which is adding pressure on pharma companies.
SpringWorks receives breakthrough status for desmoid tumour drug pharmaceutical-technology
September 03, 2019
SpringWorks Therapeutics has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for nirogacestat...
Researchers find new drug with promise for malaria treatment pharmaceutical-technology
September 03, 2019
An international research team led by the University of Glasgow has discovered a new drug that could kill the malaria-causing parasite, offering hope for the treatment of the disease.
Fasenra Granted Orphan Drug Designation americanpharmaceuticalreview
September 03, 2019
AstraZeneca announced the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Fasenra (benralizumab) for the treatment of eosinophilic oesophagitis (EoE).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page